Zurcher Kantonalbank Zurich Cantonalbank Buys 23,903 Shares of American Healthcare REIT, Inc. (NYSE:AHR)

Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 318.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,410 shares of the company's stock after buying an additional 23,903 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in American Healthcare REIT were worth $820,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of AHR. Kozak & Associates Inc. bought a new stake in shares of American Healthcare REIT during the third quarter valued at about $28,000. Tidemark LLC acquired a new position in American Healthcare REIT during the 3rd quarter valued at about $44,000. Kessler Investment Group LLC bought a new stake in shares of American Healthcare REIT during the 3rd quarter worth about $48,000. KBC Group NV acquired a new stake in shares of American Healthcare REIT in the 3rd quarter worth approximately $51,000. Finally, Kiely Wealth Advisory Group Inc. bought a new position in shares of American Healthcare REIT in the second quarter valued at approximately $30,000. 16.68% of the stock is owned by institutional investors and hedge funds.

American Healthcare REIT Stock Performance

AHR stock traded down $0.28 during mid-day trading on Friday, reaching $28.55. 1,467,941 shares of the stock traded hands, compared to its average volume of 2,157,800. American Healthcare REIT, Inc. has a 52-week low of $12.63 and a 52-week high of $29.99. The stock's fifty day moving average is $26.54 and its 200-day moving average is $20.88. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.37 and a quick ratio of 0.37.

American Healthcare REIT (NYSE:AHR - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.32 by ($0.35). American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.87%. The firm had revenue of $523.81 million during the quarter, compared to analysts' expectations of $474.26 million. The business's revenue was up 12.8% on a year-over-year basis. On average, research analysts expect that American Healthcare REIT, Inc. will post 1.42 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on AHR. Morgan Stanley upped their target price on American Healthcare REIT from $17.00 to $22.00 and gave the stock an "overweight" rating in a research report on Thursday, August 22nd. Truist Financial upped their price objective on American Healthcare REIT from $27.00 to $29.00 and gave the company a "buy" rating in a report on Friday, November 15th. Royal Bank of Canada lifted their target price on American Healthcare REIT from $28.00 to $30.00 and gave the stock an "outperform" rating in a report on Monday, November 18th. KeyCorp boosted their price target on shares of American Healthcare REIT from $16.00 to $27.00 and gave the stock an "overweight" rating in a research report on Monday, September 16th. Finally, JMP Securities raised their price objective on shares of American Healthcare REIT from $18.00 to $30.00 and gave the company a "market outperform" rating in a research report on Friday, September 20th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $25.13.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.